Search Results
Found 1 results
510(k) Data Aggregation
(106 days)
Phoenix Wound Matrix
The Phoenix Wound Matrix is intended for use in the management of wounds. Wound types include: Partial and fullthickness wounds, pressure ulcers, diabetic ulcers, chronic vascular ulcers, tunneled/undermined wounds, surgical wounds (donor sites/grafts, post-Moh's surgery, podiatric, wound dehiscence), trauma wounds (abrasions, lacerations, second degree burns, skin tears) and draining wounds.
The Phoenix Wound Matrix is a sterile, single use device intended for the management of wounds. The Phoenix Wound Matrix is a conformable, non-woven, fibrous, three-dimensional matrix. The Phoenix Wound Matrix is made from two types of polymer fibers: Poly(lactide-co-caprolactone) and Polyglycolic acid, which are bioabsorbed after degrading via hydrolysis.
This response is based on the provided text, which is a 510(k) submission summary for the Phoenix Wound Matrix. It's important to note that a 510(k) submission primarily focuses on demonstrating substantial equivalence to a predicate device, rather than proving the safety and effectiveness of new technology through a comprehensive clinical study with acceptance criteria and a detailed study design. Therefore, much of the requested information regarding detailed acceptance criteria, specific study designs (like MRMC), and ground truth establishment for AI/algorithm performance cannot be extracted from this document, as it pertains to a different type of regulatory submission (most often for novel AI/ML medical devices).
The document is a declaration of substantial equivalence for a wound matrix, not an AI/ML device. Therefore, the questions about acceptance criteria for AI algorithms, sample sizes for test and training sets, expert consensus, MRMC studies, and ground truth establishment are not applicable in this context.
However, I can extract information related to the device's performance testing from the "Performance Data" section.
Device: Phoenix Wound Matrix
Regulatory Pathway: 510(k) (seeking substantial equivalence to predicate devices)
1. Acceptance Criteria and Reported Device Performance
Since this is a traditional medical device (wound matrix) and not an AI/ML device, the "acceptance criteria" are not defined as statistical metrics for an algorithm's performance (e.g., sensitivity, specificity, AUC). Instead, they relate to biocompatibility, mechanical properties, and non-inferiority in wound healing.
Acceptance Criteria Category | Specific Tests/Assessments | Reported Device Performance |
---|---|---|
Biocompatibility | ISO 10993, Biological Evaluation of Medical Devices testing: | "ISO 10993, Biological Evaluation of Medical Devices testing has demonstrated that the device is safe." |
Specific tests conducted: | ||
- Cytotoxicity | Passed | |
- Dermal irritation | Passed | |
- Sensitization | Passed | |
- Acute systemic toxicity | Passed | |
- Genotoxicity | Passed | |
- 6-week muscle implantation | Passed (device found to be safe through this evaluation) | |
- 6-week sub-acute/sub-chronic toxicity | Passed (device found to be safe through this evaluation) | |
Mechanical Properties | Functional testing for sufficient mechanical properties | "Functional testing demonstrates that the device has sufficient mechanical properties (strength and flexibility) for unaged and aged devices." |
Wound Healing Response | Animal wound healing study in a porcine model (demonstrating no delay in wound healing response) | "An animal wound healing study in a porcine model has demonstrated that there was no delay in the wound healing response due to the subject device." (This implies a comparison to a control or standard treatment, showing non-inferiority in healing time/pattern, though specific metrics are not detailed in this summary). This is a demonstration that the device does not negatively impact the healing process, supporting its safety and effectiveness for its intended use. |
2. Sample Size and Data Provenance for the Test Set
- Sample Size for Test Set: Not explicitly stated in terms of number of wounds or animals. The text only mentions "an animal wound healing study in a porcine model."
- Data Provenance: The study was an "animal wound healing study in a porcine model." This implies a controlled laboratory setting, likely in the US given the FDA submission. It is by nature a prospective experiment in an animal model, not retrospective human data.
3. Number of Experts and Qualifications for Ground Truth
- Not applicable. This device is a wound dressing, not an AI/ML diagnostic device requiring expert interpretation for ground truth establishment. The performance data is based on direct biological and mechanical testing.
4. Adjudication Method for the Test Set
- Not applicable. As above, no human expert adjudication is described for the performance testing of this physical device.
5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study
- No. This is not an AI/ML diagnostic or image-based device. An MRMC study is not relevant for evaluating the performance of a wound matrix.
6. Standalone (Algorithm Only) Performance
- Not applicable. There is no algorithm associated with this physical wound matrix device for standalone performance evaluation.
7. Type of Ground Truth Used
- Biological and Physical Measurements: For biocompatibility, the ground truth is established by standard ISO 10993 biological assays (e.g., cell viability for cytotoxicity, skin reaction for irritation/sensitization, histological examination for implantation studies). For mechanical properties, it's defined by laboratory stress/strain measurements. For wound healing, it's based on observed healing progression in the animal model.
8. Sample Size for the Training Set
- Not applicable. This device does not use machine learning or AI models, so there is no concept of a "training set."
9. How Ground Truth for Training Set was Established
- Not applicable. As there is no training set, this question is irrelevant.
Ask a specific question about this device
Page 1 of 1